Home › Posts tagged Schubförmige Multiple Sklerose
Blog Archives

Schwere Nebenwirkungen: Das MS-Arzneimittel Daclizumab (Zinbryta) weltweit vom Markt genommen

Posted on by by Posted in Behördliche Mitteilung, Gravierende Unerwünschte Nebenwirkung, Marktrückzug, Thasso Post, Theragenomische Medizin No Comments ↓

02. März 2018 – Daclizumab (Zinbryta) wurde im Mai 2016 in den USA, im Juli 2016 in der Europäischen Union (EU) und im Januar 2017 auch in der Schweiz zur Behandlung der schubförmig auftretenden Multiplen Sklerose auf dem Markt zugelassen. Daclizumab (Zinbryta) ist ein therapeutischer humanisierter monoklonaler Antikörper gegen den Interleukin-2-Rezeptor (genauer: gegen die α-Kette CD25),

…

Read more ›

Tags: , , , , , , , , ,

thasso: spenden

thasso: zustände

thasso: kurzmitteilungen

thasso post: magazin

View my Flipboard Magazine.

thasso: kategorien

thasso: archive

thasso: einfacher chat

You must be a registered user to participate in this chat.

RSS random genetics

  • Gene network sparks future autism treatment December 5, 2019
    A mutated gene found in people with intellectual disabilities that could be targeted for treatment has been identified by an international team including University of Queensland researchers.
  • Tick, tock: How stress speeds up your chromosomes' aging clock December 5, 2019
    Ageing is an inevitability for all living organisms, and although we still don't know exactly why our bodies gradually grow ever more decrepit, we are starting to grasp how it happens.
  • Genome testing for siblings of kids with autism may detect ASD before symptoms appear December 5, 2019
    One of the key priorities of interventions for autism spectrum disorder (ASD) is starting early, with some evidence showing infants as young as seven months old could benefit. Yet, most children in North America aren't diagnosed with ASD until they're over four years of age. New research led by The Hospital for Sick Children (SickKids) […]
  • 2019: the year gene therapy came of age December 5, 2019
    In the summer, a mother in Nashville with a seemingly incurable genetic disorder finally found an end to her suffering—by editing her genome.
  • Scientists create 'epigenetic couch potato' mouse December 4, 2019
    Why is it that some people love to exercise, and others hate it? Most people would assume it's all due to genetics, but a new Baylor College of Medicine led study in mice shows for the first time that a different molecular level of regulation—epigenetics—plays a key role in determining one's innate drive to exercise. […]

RSS random science

  • New report shows dramatic health benefits following air pollution reduction December 6, 2019
    Reductions in air pollution yielded fast and dramatic impacts on health-outcomes, as well as decreases in all-cause morbidity, according to findings in 'Health Benefits of Air Pollution Reduction,' new research published in the American Thoracic Society's journal, Annals of the American Thoracic Society.
  • Scientists see defects in potential new semiconductor December 5, 2019
    A research team has reported seeing, for the first time, atomic scale defects that dictate the properties of a new and powerful semiconductor. The study, published earlier this month in the journal Physical Review X, shows a fundamental aspect of how the semiconductor, beta gallium oxide, controls electricity.
  • Squid pigments have antimicrobial properties December 5, 2019
    Ommochromes, the pigments that color the skin of squids and other invertebrates, could be used in the food and health sectors for their antioxidant and antimicrobial properties. This is confirmed by the analyses carried out by researchers from the University of Sonora in Mexico and the Miguel Hernández University in Spain.
  • The Lancet: First long-term estimates suggest link between cholesterol levels and risk of heart disease and stroke December 5, 2019
    The observational and modelling study which used individual-level data from almost 400,000 people, published in The Lancet, extends existing research because it suggests that increasing levels of non-HDL cholesterol may predict long-term cardiovascular risk by the age of 75 years. Past risk estimates of this kind are based on 10-year follow-up data.
  • Wildlife in tropics hardest hit by forests being broken up December 5, 2019
    Tropical species are six times more sensitive to forests being broken up for logging or farming than temperate species, says new research.
Top